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The reported incidence of neoplasia in the extinct human lineage is rare, with only a few confirmed 
cases of Middle or Later Pleistocene dates reported. It has generally been assumed that pre-
modern incidence of neoplastic disease of any kind is rare and limited to benign conditions, 
but new fossil evidence suggests otherwise. We here present the earliest identifiable case of 
malignant neoplastic disease from an early human ancestor dated to 1.8–1.6 million years old. 
The diagnosis has been made possible only by advances in 3D imaging methods as diagnostic 
aids. We present a case report based on re-analysis of a hominin metatarsal specimen (SK 7923) 
from the cave site of Swartkrans in the Cradle of Humankind, South Africa. The expression 
of malignant osteosarcoma in the Swartkrans specimen indicates that whilst the upsurge in 
malignancy incidence is correlated with modern lifestyles, there is no reason to suspect that 
primary bone tumours would have been any less frequent in ancient specimens. Such tumours 
are not related to lifestyle and often occur in younger individuals. As such, malignancy has a 
considerable antiquity in the fossil record, as evidenced by this specimen.
Introduction
The reported incidence of neoplastic disease in the extinct human lineage is rare. Only a few confirmed cases 
of Middle or Later Pleistocene dates (780 000 to 120 000 years old) have been reported.1,2 It is generally 
assumed that pre-modern incidence of neoplastic disease of any kind is rare and limited to benign conditions, 
but new fossil evidence suggests this is not so. We here present the earliest identifiable case of malignant 
neoplastic disease from an early human ancestor dated to 1.8–1.6 million years old (Ma). The diagnosis is 
possible only because of advances in 3D imaging methods as an aid in diagnosis. 
A neoplasm (‘new-growth’ or tumour) is defined as a mass of localised tissue growth in which cellular 
proliferation is no longer subject to the effects of normal growth-regulating mechanisms.1,2 A tumour 
may be benign or malignant in nature; malignant tumours are often colloquially referred to as a cancer.3 
Malignancy is the primary cause of death in industrialised countries and the second foremost cause of 
death in developing countries.4,5 Since 1999, malignancy has surpassed cardiac disease as the leading 
cause of death for humans younger than 85 years in the USA6, and is often perceived to be a disease of 
modernity7-9. At present, true neoplastic diseases seem to be restricted to complex vertebrate animals. 
Only one observation of true malignancy has been described in one of the simpler living vertebrates, 
specifically hepatomas in the cartilaginous skeleton of the jawless hagfish.2 This is a very important case 
for the comparative pathology of malignancy, because lampreys are among the simplest living vertebrates.
The fact that malignancy has great antiquity is demonstrated from the fossil record. The earliest definitive 
evidence for neoplastic disease comes from pre-Cenozoic contexts, with purported cases of neoplasm 
found in fossil fish from the Upper Devonian. The earliest unequivocal case dates from 300 Ma, with 
evidence of benign osteoma with focal hyperostosis affecting a partial skeleton of the fish Phanerosteon 
mirabile from the North American Lower Carboniferous.2 Later cases include diagnoses of benign 
haemangioma and eosinophilic granuloma in Jurassic dinosaurs; benign osteoma in mosasaurs; 
and haemangioma, metastatic disease, desmoplastic fibroma, and osteoblastoma in Cretaceous 
hadrosaurs.10,11 Benign osteoid osteoma and osteoblastoma have been identified in European mammoths 
dating from 24 to 23 thousand years ago (ka).12 Evidence for neoplastic disease is not unknown in the 
human fossil, archaeological and historical records,1,3,13 but is generally considered rare. Historically, the 
earliest fossil evidence for neoplastic disease in the human lineage was suggested to be from a mandible 
of archaic Homo from Kanam in Kenya. This lesion has variously been attributed to osteosarcoma, bone 
keloid, Burkitt’s lymphoma, or traumatic osteomyelitis.2,14-17 The first substantive evidence for hominin 
neoplastic disease is derived from a juvenile skeleton of Australopithecus sediba, dated to 1.98 Ma, from 
the site of Malapa in South Africa. An invasive spinal lesion has been attributed by Randolph-Quinney 
and colleagues to benign osteoid osteoma, a non-malignant tumour.18 Later significant evidence for 
near-human neoplastic disease is suggested by Monge and colleagues19, who present a case of fibrous 
dysplasia from a Neanderthal rib dated to 120 000 ka from the site of Krapina.
Here we present the earliest fossil evidence for malignant neoplastic disease in the hominin record, with 
a detailed description and differential diagnosis of malignant osteosarcoma. Our report is based on re-
analysis of a hominin metatarsal specimen (SK 7923) (gen. et spec. indet.) from the cave site of Swartkrans 
in the Cradle of Humankind, South Africa. SK 7923 is a metatarsal recovered from the Member 1 Hanging 
Remnant, which has yielded fossils of both Homo ergaster and Paranthropus robustus.20 Several faunal 
estimates have indicated the age of the Hanging Remnant at between 1.5 Ma and 1.8 Ma.21-23 Recent 
electron spin resonance dating has estimated the age of the Hanging Remnant of Swartkrans at 1.6 Ma.24 
The oldest southern African specimens of early Homo and Paranthropus present around 2.1–1.9 Ma in 
Member 1, and are recorded until around 1.0–0.6 Ma in Member 3 of the Swartkrans cave.25
2South African Journal of Science  http://www.sajs.co.za
Volume 112 | Number 7/8 
July/August 2016
Swartkrans hominin site
Swartkrans was discovered in 1948. The site is situated approximately 
40 km northwest of Johannesburg, on the bank of the Blaauwbank River 
in the province of Gauteng, South Africa. It is arguably one of the most 
important palaeocave sites in southern Africa, if not globally, and is best 
known for its rich heritage of Paranthropus robustus fossils, and purported 
evidence for early hominin use of controlled pyrotechnology. During much 
of their early research, Broom and his assistant Robinson excavated a 
considerable sample of hominin remains attributable to Paranthropus 
robustus and Homo from the site.26,27 Swartkrans was the first site where 
these two genera of hominins were considered to be contemporary. 
After an approximately 12-year hiatus of non-activity, Brain’s subsequent 
excavations at Swartkrans from the mid-1960s to the mid-1980s 
produced a significant addition to the faunal20, fossil and archaeological 
collection. From the total number of specimens obtained at the Swartkrans 
site, 415 accessioned specimens are identified as hominin.20 Brain’s work 
demonstrated that the stratigraphy of the site was much more complex 
than originally posited. Brain subsequently demonstrated five members 
at Swartkrans.22 Member 1 consists of two distinct masses, the Hanging 
Remnant and Lower Bank22, each of them yielding Homo ergaster and 
Paranthropus robustus28. Homo and Paranthropus have been discovered 
from Member 2.28
SK 7923 case study
SK 7923 is a left 5th metatarsal, preserving the proximal diaphysis and 
much of the distal portion, but lacking the articular end. The specimen 
is hominin, but cannot be allocated to a specific taxon. Pathologically, 
SK 7923 presents a growth on the proximo-ventral aspect of the shaft. 
Here, an irregular hemi-spherical mass abuts the cortex (Figure 1), 
measuring 5.2 mm x 4.7 mm. The specimen was originally studied as 
part of an unpublished doctoral thesis, where the morphology led one of 
us (R.F.) to diagnose osteoid osteoma. However, recent internal imaging 
has led to a re-evaluation of the pathology. 
The bone was examined using micro-focus X-ray computed tomography 
(µXCT) at the South African Nuclear Centre for Radiography and 
Tomography (located at the South African Nuclear Energy Corporation, 
NECSA). The bone was scanned by F.d.B. and J.W.H. using a Nikon 
XTH225ST µXCT system, at an energy potential of 100 kV and resolution 
of 17 microns. Reconstruction was performed by E.J.O. and P.R.Q. using 
Avizo Amira 5.4 to generate both 2D orthoslice and 3D surface rendered 
views. The cross-section shows that the hemispherical mass is not fully 
fused to or integrated with the cortex, but adheres to the bone surface, 
displaying an irregular spongy woven bone texture with a cauliflower-like 
external appearance (Figure 2a). The cortical bone directly underlying 
the mass is covered with a thin layer of new woven bone, with a Codman 
triangle displayed at the margins. The texture is granular and exhibits 
ellipsoid lytic lesions in transverse view. There is localised sub-periosteal 
invasion by the mass into the cortex (Figure 2a). Surprisingly, µXCT 
showed much of the medullary cavity to be infilled with bone, with clear 
internal remodelling and de-novo bone formation (Figure 2b). Inside the 
cortex are several irregular and large circular voids, caused by bony 
encapsulation of normal vascular channelling found within the endosteal 
surface of the medullary cavity. The remaining medullary space is 
obliterated by new bone growth.
A number of bone-forming conditions should be considered in the differential 
diagnosis: chondrosarcoma, Ewing’s sarcoma, metastatic carcinoma, 
osteochondroma, osteoblastoma and osteosarcoma (see Supplementary 
Appendix for a more detailed breakdown).3,29-46 Osteosarcoma usually 
starts in the medulla and characteristically arises within the metaphysis of 
long bones, growing circumferentially through the cortex into soft tissue 
and raising the periosteum. This seems to have occurred in SK 7923, with 
a Codman triangle visible. Osteosarcoma (osteogenic sarcoma) prefers 
fast-growing regions and usually occurs around the knee. It presents in 
metatarsals in less than 1% of clinical cases. According to Vigorita47, the 
periosteal reaction may have a ‘sunburst’ appearance, which is to some 
extent visible in Figure 2a. Given the internal and external morphology 
of this specimen, it seems most likely that this pathology is attributable 
to osteosarcoma, with a strong possibility of the parosteal variant of 
this condition. Diagnosis was supported by µXCT imaging of a modern 
clinically diagnosed case of osteosarcoma of the distal femur. Comparison 
of Figures 2b and 2c shows clear similarities between the appearance of 
the fossil and modern medullary infills.
Osteosarcoma is a primary malignant tumour that typically exhibits 
cortical and medullary disruption and some degree of mineralisation. 
It also typically shows aggressive periosteal new bone reaction, which 
can include either lamination, Codman triangle, or spiculated sunburst 
reaction. The most common form is central osteogenic sarcoma, which 
could be osteoblastic or osteolytic in nature, or both. This typically occurs 
in the metaphyseal and diaphyseal area of the major long bones. Parosteal 
osteosarcoma is the most common type of juxtacortical or surface 
osteosarcoma. This often presents as a lobulated ‘cauliflower’ mass 
with central ossification adjacent to the bone, and may infiltrate the bone 
marrow. Bone destruction is rare, but when present is regional. 
Figure 1: SK 7923 , a hominin 5th metatarsal, exhibits a hemi-spherical bony mass located on the proximo-ventral aspect of the shaft, abutting the cortical 
bone surface. P – proximal, D – distal, V – ventral. 
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Most parosteal osteosarcomas are found in the metaphyseal region of 
long tubular bones. The most common site is the distal femur, followed 
by the upper shaft of the tibia, and then the proximal humerus.
Functionally, this malignancy may have presented secondary conse-
quences in our case study. The belly of abductor digitii minimi may have 
been displaced laterally, and with fibularis brevis and f. tertius inserting 
just proximal and distal to the growth, some influence on gait was likely. 
The presence of sub-periosteal bone formation in the form of a Codman 
triangle, cortical invasion, spiculated mass abutting the exosteum, and 
aggressive medullary infilling (including the combination of trabeculated 
and avascular bone) indicates that what was originally diagnosed 
as a benign exosteal growth is now shown to represent a malignant 
bone malignancy. This change in diagnosis is entirely the result of 
advances in high-resolution 3D imaging, together with the judicious 
use of comparative clinical pathology. It is thus possible that cases 
of malignancy might remain unknown in fossil assemblages awaiting 
imaging and discovery.
Discussion
This case highlights a significant issue with regard to modern clinical 
incidence and expression of neoplastic disease, and malignancy in 
particular. That is, how can we understand ancient disease evolution 
when sample sizes are extremely small? As noted above7-9, malignancy 
is perceived as a disease of modernity. However, it is worth noting that 
primary skeletal malignant tumours are not commonly encountered in 
the modern clinical environment, and although rare they do feature in the 
archaeological and fossil record3,18. Historically, factors of preservation 
have limited the study of human neoplasia to the skeleton, from which 
the confident diagnosis of tumours has been problematical.48 Recent 
work on artificially mummified Egyptian remains has suggested to some 
scholars9,49 that malignancy was almost absent in pre-modern human 
populations. For example, Gray49 reported no radiological confirmation 
of malignant neoplasia among 193 examined Egyptian mummies. 
However, we view this assertion as tautological, because the samples on 
which the claim is based are not representative of the bulk of the human 
species living in antiquity; they represent only a small fraction of all 
humans living at that time50. From the global historical sample available 
to us for study, malignancy does exist, albeit rarely – and a subset of 
those cases include osteosarcoma. Probable pre-modern cases are 
reported from Hawaii51, the Czech Republic52, and the Peruvian Andes1.
The precise range of causes underlying malignancies is still largely 
unknown. Where causes have been established, these are generally 
understood to fall into three categories: physical, chemical, and viral.1 
Physical causes include being exposed to ultraviolet light (which 
increases the risk of basal cell carcinoma and malignant melanoma) 
and levels of background radiation.1 Causative examples in the historical 
modern environment include the effects of radiation from the dropping 
of atomic bombs on Japan during World War II, which has been linked 
to an escalation in myelogenous leukaemia and thyroidal malignancy.1 
Chemical carcinogens in humans have historically been known to target 
skin and lungs, urinary bladder, and nasal sinuses and pleura. Potts 
demonstrated a relationship between scrotal malignancy in chimney 
sweepers and exposure to soot as early as 1775.53 Many chemicals are 
widely accepted to be carcinogenic. Radon from granite, for example, is 
a radioactive gas causing lung malignancy.1 Several viruses can cause 
malignancy in animals, and the association of some viruses with human 
malignancy is considerable. Examples include human papilloma virus 
(cervix malignancy), hepatitis B or C virus (liver malignancy), Epstein-
Barr virus (non-Hodgkin lymphomas and nasopharyngeal malignancy), 
and human immunodeficiency virus (linked to non-Hodgkin lymphoma 
and Kaposi sarcoma).1 
Whilst most modern human malignancies are thought to be caused 
by environmental agents of a chemical nature, the evidence for this 
is not entirely conclusive.1,p.373 The internal environment, namely 
Figure 2: (a) Axial micro-CT orthoslice indicating (i) reactive new bone formation subperiosteally forming a Codman triangle, (ii) ossified exophytic 
(cauliflower-like) and/or spiculated mass adjacent to the bone, (iii) localised sub-periosteal invasion by the mass into the cortex, (iv) remodelled 
bone infill; (b) transverse rendered view of SK 7923; (c) transverse rendered view of modern clinical case of osteoblastic osteosarcoma with 
aggressive local medullary infilling (Courtesy: Department of Anatomy, University of Pretoria). Note (v) the homologous combination of spongy 
and solid bone between the fossil and clinical specimens.
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diet and lifestyle, is thought to play a significant role in malignancy 
disposition. Some malignancies are certainly triggered by modern 
lifestyle factors, such as smoking, drinking (which can lead to liver and 
oesophageal malignancy), sunbathing, and obesity (which can lead to 
gastrointestinal gut malignancy).1 Pesticides and industrial chemicals 
can cause malignancy, but their contribution is thought to be relatively 
minor. Of perhaps greatest impact is colorectal malignancy, which kills 
approximately 700 000 people every year worldwide8, and is most 
prevalent in developed countries such as USA and Europe. The lowest 
incidence occurs in underdeveloped countries in Africa, which have 
vastly different dietary regimes available to the population. Brody8 has 
named colorectal cancer a disease of modernity and development. In 
other words, economic growth is associated with a rise in the incidence 
of colorectal malignancy, with corresponding lifestyle changes possibly 
playing a strong role in the prevalence of this disease. An example is 
China, where a marked increase in the prevalence of colorectal malig-
nancy is occurring.8 
In addition, whilst the modern lifestyles of humans may enhance the 
frequency of cancer, longer life expectancies mean malignancy would 
logically occur at a higher rate among modern people than in our 
prehistory. We are unable to assess the age at death of the Swartkrans 
SK 7923 hominin (other than skeletally adult), but it was likely to 
have been substantially less than modern life expectancy, based on 
demographic studies of early hominin taxa54.
The expression of malignant osteosarcoma in the Swartkrans SK 7923 
specimen indicates that whilst the explosion of malignancy incidence is 
clearly correlated with the hazards of the modern world and increased 
life expectancy, primary bone tumours evidently occurred throughout 
history. Then, as now, such tumours would have occurred predominantly 
in younger individuals. Neoplastic disease has considerable antiquity, 
as evidenced by this specimen and further supported by numerous 
published case studies of benign neoplasms with deep antiquity in the 
fossil record, as noted above.1-3,10-12,18,55,56 The theory that the almost 
total lack of malignancies in Egyptian mummies indicates that the 
disease occurs only in industrialised societies9 is thus questionable.
The lack of substantial evidence of malignancy in the fossil and bio-
archaeological records might arguably be an artefact of preservation, 
or of sampling bias and tiny sample sizes, or of analytical techniques 
or the application of inefficient imaging modalities57. For example, the 
results would differ if plain radiography or clinical magnetic resonance 
imaging are used rather than micro-computed tomography. The 
absolutely small sample sizes arise from short life expectancy among 
pre-modern societies. Hence, the rare incidence of cancer cases found 
in the record can be seen as most likely non-representative, and should 
not be construed as indicating the true prevalence of disease. It is 
important to note that because of the worldwide demographic transition 
and average increased age at death for humans, non-primary bone 
malignancy can be expected to occur at a higher rate today than in pre-
transition populations.50 
As highlighted in the introduction, malignancy occurs in almost all 
metazoans, suggesting that the mechanisms of malignancy have an 
extremely old evolutionary history. For example, neoplasms have been 
recorded in dinosaurs and other fossil forebears.2,11,56 A number of 
oncogenes are particularly archaic, with their antecedents exhibited 
in some form in primitive common ancestor metazoans of chordates 
and arthropods.55,58 Thus, the capacity for malignancy is ancient, 
and the higher incidence of malignancy in today’s developed and 
developing world may be related to the unique interaction between 
environmental factors – which have no parallel in prehistory59. It is 
also important to note that modern non-invasive imaging techniques 
(such as micro-computed tomography or phase-contrast synchrotron 
tomography), together with the appropriate use of clinical homologues, 
play a considerable role in enabling accurate diagnoses. These new 
techniques hold considerable potential for re-investigating previously 
reported palaeopathological lesions.
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